Back to Search Start Over

Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement

Authors :
Fernando Alfonso
Marco Barbanti
Alexandre Abizaid
Howard C. Herrmann
John Lisko
Luis Nombela-Franco
Eric Durand
Julio Andrea
Sandro Sponga
Oliver Husser
Vincent Auffret
Ander Regueiro
Susheel Kodali
Victoria Vilalta
Marcos Antonio Marino
Marouane Boukhris
Asim N. Cheema
Saif Siddiqui
Isaac Pascual
David Holzhey
Paolo Olivares
Josep Rodés-Cabau
Maria Cristina Ferreira
Hervé Le Breton
Norman Mangner
Vinicius Esteves
Tarun Chakravarty
Vicenç Serra
Martin Landt
Guglielmo Mario Actis Dato
Abdullah Alkhodair
Francesco Giannini
Dominique Himbert
Tomasz Gasior
Wojtek Wojakowski
Valter C. Lima
Azeem Latib
Utz Kappert
Antonio L. Bartorelli
Annapoorna Kini
Enrique Gutiérrez-Ibañes
Juan C. Castillo
Mohamed Abdel-Wahab
Erika Muñoz-García
José Armando Mangione
Clement Servoz
Ignacio J. Amat-Santos
Francisco Campelo-Parada
Stefan Stortecky
Francesco Rosato
Luca Testa
Marina Urena
Luisa Salido
Ugolino Livi
Alexandre Siciliano Colafranceschi
Chekrallah Chamandi
Lisa Crusius
Samir R. Kapadia
Harindra C. Wijeysundera
Roger R. Godinho
Stamatios Lerakis
Frédéric Maes
Jean Bernard Masson
Rosana Hernández-Antolín
Didier Tchetche
Antonio Miceli
Fabio Sandoli de Brito
David del Val
Axel Linke
Lars Søndergaard
Costanza Pellegrini
Alberto Alperi
Jan Malte Sinning
John G. Webb
Claudia Fiorina
Kim Won-Keun
Hélène Eltchaninoff
Henrique Barbosa Ribeiro
Nikolaj Ihlemann
Rafael Romaguera
Philippe Gervais
Raj Makkar
Université Laval [Québec] (ULaval)
Universität Leipzig [Leipzig]
Technische Universität Dresden = Dresden University of Technology (TU Dresden)
Endothélium, valvulopathies et insuffisance cardiaque (EnVI)
Université de Rouen Normandie (UNIROUEN)
Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
CHU Pontchaillou [Rennes]
Laboratoire Traitement du Signal et de l'Image (LTSI)
Université de Rennes 1 (UR1)
Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Hôpital Européen Georges Pompidou [APHP] (HEGP)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)
Hôpital de Rangueil
CHU Toulouse [Toulouse]
Clinique Pasteur [Toulouse]
Universität Leipzig
Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)
Source :
Journal of the American College of Cardiology, Journal of the American College of Cardiology, Elsevier, 2021, 77 (18), pp.2276-2287. ⟨10.1016/j.jacc.2021.03.233⟩, Journal of the American College of Cardiology, 2021, 77 (18), pp.2276-2287. ⟨10.1016/j.jacc.2021.03.233⟩, Journal Of The American College Of Cardiology, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Publication Year :
2021
Publisher :
HAL CCSD, 2021.

Abstract

BACKGROUND Stroke is one of the most common and potentially disabling complications of infective endocarditis (IE). However, scarce data exist about stroke complicating IE after transcatheter aortic valve replacement (TAVR). OBJECTIVES The purpose of this study was to determine the incidence, risk factors, clinical characteristics, management, and outcomes of patients with definite IE after TAVR complicated by stroke during index IE hospitalization. METHODS Data from the Infectious Endocarditis after TAVR International Registry (including 569 patients who developed definite IE following TAVR from 59 centers in 11 countries) was analyzed. Patients were divided into two groups according to stroke occurrence during IE admission (stroke [S-IE] vs. no stroke [NS-IE]). RESULTS A total of 57 (10%) patients had a stroke during IE hospitalization, with no differences in causative microorganism between groups. S-IE patients exhibited higher rates of acute renal failure, systemic embolization, and persistent bacteremia (p < 0.05 for all). Previous stroke before IE, residual aortic regurgitation >= moderate after TAVR, balloon-expandable valves, IE within 30 days after TAVR, and vegetation size >8 mm were associated with a higher risk of stroke during the index IE hospitalization (p < 0.05 for all). Stroke rate in patients with no risk factors was 3.1% and increased up to 60% in the presence of >3 risk factors. S-IE patients had higher rates of in-hospital mortality (54.4% vs. 28.7%; p < 0.001) and overall mortality at 1 year (66.3% vs. 45.6%; p < 0.001). Surgical treatment was not associated with improved outcomes in S-IE patients (in-hospital mortality: 46.2% in surgical vs. 58.1% in no surgical treatment; p = 0.47). CONCLUSIONS Stroke occurred in 1 of 10 patients with IE post-TAVR. A history of stroke, short time between TAVR and IE, vegetation size, valve prosthesis type, and residual aortic regurgitation determined an increased risk. The occurrence of stroke was associated with increased in-hospital and 1-year mortality rates, and surgical treatment failed to improve clinical outcomes. (C) 2021 by the American College of Cardiology Foundation.

Details

Language :
English
ISSN :
07351097 and 15583597
Database :
OpenAIRE
Journal :
Journal of the American College of Cardiology, Journal of the American College of Cardiology, Elsevier, 2021, 77 (18), pp.2276-2287. ⟨10.1016/j.jacc.2021.03.233⟩, Journal of the American College of Cardiology, 2021, 77 (18), pp.2276-2287. ⟨10.1016/j.jacc.2021.03.233⟩, Journal Of The American College Of Cardiology, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Accession number :
edsair.doi.dedup.....5ab6a73c96cbcd2041e99550ca0f613a